François-Xavier has joined PDCI Market Access as a Senior Health Economist.

He is responsible for leading the conception and development of strategic, evidence-based economic components for submission to Canadian Health Technology Assessment (HTA) bodies and public/private payers. Among other roles, he ensures that PDCI is that forefront of trends and policy matters affecting HTA, pricing, market access and pharmaceutical industry.

François-Xavier has over 5 five years of experience at L’Institut national d’excellence en santé et en services sociaux (INESSS), working as a health economics advisor. His experience as a practicing pharmacist has allowed him to have a quick and thorough understanding of the clinical context, the patient needs and the economical considerations that pertain to a wide range of health technologies. 

François-Xavier holds a Doctor of Pharmacy (PharmD) degree and a Master degree in Pharmacoeconomics from the Université de Montréal in Quebec. François-Xavier can be reached by email at Francois-Xavier.Houde@pdci.ca. 

Please join us in welcoming François-Xavier to the PDCI team!